ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
No bidding war for Loxo, so did Lilly overpay? Don’t rush to judgment, analysts say
January 21, 2019When Eli Lilly announced during the recent J.P. Morgan Healthcare Conference that it would buy Loxo Oncology for $8 billion—a 68% premium—some analysts assumed there must have been a bidding war for the developer of targeted cancer drugs. But SEC document
Pharma Sources Insight January 2025
